Related Experiment Videos
Ocular manifestations of cardiovascular and hematologic disorders
1University of California-Davis, Sacramento, California, USA.
Insights
Recent research highlights how cardiovascular and hematologic disorders impact eye health. Understanding these connections aids in diagnosing and managing ocular conditions linked to blood pressure, vascular issues, and blood diseases.
Area of Science:
- Ophthalmology
- Cardiology
- Hematology
Background:
- Cardiovascular and hematologic disorders can cause significant ocular pathology.
- Ocular manifestations are increasingly understood in relation to systemic diseases.
Purpose of the Study:
- To review recent findings on ocular complications of cardiovascular and hematologic disorders.
- To emphasize the link between systemic conditions and eye health.
Main Methods:
- Literature review of recent publications.
- Analysis of ophthalmic pathology related to vascular and blood disorders.
Main Results:
- Carotid and vertebral artery lesions cause varied ophthalmic issues.
- Blood pressure disorders affect intraocular pressure and glaucoma.
- Cardiovascular risk factors contribute to anterior ischemic optic neuropathy.
- Hematologic disorders lead to serious ocular morbidity.
Conclusions:
- Ocular manifestations are key indicators of underlying cardiovascular and hematologic conditions.
- Further research is needed to fully understand and manage these complex relationships.
Abstract:
During the past year, there has been increased understanding of the ocular manifestations of various cardiovascular and hematologic disorders. Carotid and vertebral artery lesions may lead to significant and varied ophthalmic pathology. Disorders of blood pressure may influence the intraocular pressure and play a role in the progression of glaucoma. Cardiovascular risk factors such as smoking, hyperlipidemia, hypertension, and diabetes mellitus, may also play a role in the development of anterior ischemic optic neuropathy. Several cardiac anomalies as well as the cardiac use of streptokinase have been reported to have secondary ocular involvement. Both benign and malignant hematologic disorders may result in serious ocular morbidity. Recent publications have focused on the secondary ophthalmic complications from the hemoglobinopathies, problems with blood viscosity, the lymphomas, the leukemias, and bone marrow transplantation.